Miriam Marqués

1.8k total citations
23 papers, 1.2k citations indexed

About

Miriam Marqués is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Miriam Marqués has authored 23 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Surgery. Recurrent topics in Miriam Marqués's work include Cancer-related Molecular Pathways (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Miriam Marqués is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). Miriam Marqués collaborates with scholars based in Spain, Austria and United Kingdom. Miriam Marqués's co-authors include Ana C. Carrera, Amit Kumar, Zaira García, Isabel Cortés, Miguel R. Campanero, Carmen Hernández, Francisco X. Real, Susana Zuluaga, Rosa Ana Lacalle and Santos Mañes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The EMBO Journal.

In The Last Decade

Miriam Marqués

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miriam Marqués Spain 19 799 329 279 145 135 23 1.2k
Brian Theisen United States 8 848 1.1× 472 1.4× 208 0.7× 95 0.7× 195 1.4× 19 1.4k
Mélanie Tichet France 16 674 0.8× 441 1.3× 303 1.1× 103 0.7× 196 1.5× 20 1.1k
Kacper Jankowski United States 12 714 0.9× 534 1.6× 346 1.2× 63 0.4× 188 1.4× 15 1.4k
Charlotte Rorsman Sweden 10 668 0.8× 182 0.6× 206 0.7× 112 0.8× 126 0.9× 15 1.1k
Jacqueline Lesperance United States 16 819 1.0× 478 1.5× 248 0.9× 143 1.0× 205 1.5× 25 1.2k
Kalyani Penta United States 15 955 1.2× 487 1.5× 271 1.0× 111 0.8× 120 0.9× 21 1.6k
Takako Ooshio Japan 16 1.0k 1.3× 233 0.7× 185 0.7× 292 2.0× 177 1.3× 28 1.5k
Vinay Sagar United States 19 712 0.9× 361 1.1× 142 0.5× 89 0.6× 231 1.7× 46 1.3k
Christine Gjerdrum Norway 3 514 0.6× 488 1.5× 385 1.4× 148 1.0× 158 1.2× 6 1.1k
Kumar Sukhdeo United States 12 969 1.2× 565 1.7× 169 0.6× 255 1.8× 199 1.5× 28 1.5k

Countries citing papers authored by Miriam Marqués

Since Specialization
Citations

This map shows the geographic impact of Miriam Marqués's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Marqués with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Marqués more than expected).

Fields of papers citing papers by Miriam Marqués

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Marqués. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Marqués. The network helps show where Miriam Marqués may publish in the future.

Co-authorship network of co-authors of Miriam Marqués

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Marqués. A scholar is included among the top collaborators of Miriam Marqués based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Marqués. Miriam Marqués is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marqués, Miriam, Natalia del Pozo, Jaime Martínez de Villarreal, et al.. (2023). Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance. Molecular Cancer Therapeutics. 22(5). 616–629. 3 indexed citations
2.
Zagorac, Sladjana, et al.. (2023). Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities. European Urology Oncology. 6(4). 366–375. 29 indexed citations
3.
Font, Albert, Montserrat Domènech, José Luis Ramírez, et al.. (2023). Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features. Frontiers in Oncology. 13. 1155244–1155244. 1 indexed citations
4.
Marqués, Miriam, Robin Tranchant, Luis C. Fernández, et al.. (2020). Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features. Cancer Research. 80(4). 843–856. 21 indexed citations
5.
Font, Albert, Montserrat Domènech, Raquel Benítez, et al.. (2020). Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy. Cancers. 12(7). 1784–1784. 34 indexed citations
6.
Lobo, Víctor J. Sánchez‐Arévalo, Rosy Favicchio, William Greenhalf, et al.. (2016). Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors. Molecular Cancer Therapeutics. 15(2). 323–333. 27 indexed citations
7.
Gubern, Albert, Manel Joaquin, Miriam Marqués, et al.. (2016). The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells. Molecular Cell. 64(1). 25–36. 71 indexed citations
8.
Dueñas, Marta, Mónica Martínez‐Fernández, Ramón Garcı́a-Escudero, et al.. (2013). PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors. Molecular Carcinogenesis. 54(7). 566–576. 45 indexed citations
9.
Cortés, Isabel, Susana Zuluaga, Vincenzo Calvanese, et al.. (2012). p85β phosphoinositide 3-kinase subunit regulates tumor progression. Proceedings of the National Academy of Sciences. 109(28). 11318–11323. 54 indexed citations
10.
Hafner, Christian, Agustí Toll, Julie Earl, et al.. (2010). Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors. Proceedings of the National Academy of Sciences. 107(48). 20780–20785. 63 indexed citations
11.
Marqués, Miriam, Amit Kumar, Ana Poveda, et al.. (2009). Specific function of phosphoinositide 3-kinase beta in the control of DNA replication. Proceedings of the National Academy of Sciences. 106(18). 7525–7530. 72 indexed citations
12.
Marqués, Miriam, Amit Kumar, Emilio Hirsch, et al.. (2008). Phosphoinositide 3‐kinase gamma; participates in T cell receptor‐induced T cell activation.. The FASEB Journal. 22(S1). 25 indexed citations
13.
Marqués, Miriam, Amit Kumar, Emilio Hirsch, et al.. (2007). Phosphoinositide 3–kinase γ participates in T cell receptor–induced T cell activation. The Journal of Experimental Medicine. 204(12). 2977–2987. 79 indexed citations
14.
Marqués, Miriam, et al.. (2007). A cascade involving p85, Cdc42 and septin 2 regulates cytokinesis. Biochemical Society Transactions. 35(2). 222–224. 10 indexed citations
15.
Kumar, Amit, Miriam Marqués, & Ana C. Carrera. (2006). Phosphoinositide 3-Kinase Activation in Late G 1 Is Required for c-Myc Stabilization and S Phase Entry. Molecular and Cellular Biology. 26(23). 9116–9125. 41 indexed citations
16.
Cerveira, Nuno, Cecília Correia, Susana Bizarro, et al.. (2006). SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23). Oncogene. 25(45). 6147–6152. 34 indexed citations
17.
García, Zaira, Miriam Marqués, Isabel Cortés, et al.. (2006). A PI3K activity‐independent function of p85 regulatory subunit in control of mammalian cytokinesis. The EMBO Journal. 25(20). 4740–4751. 59 indexed citations
18.
García, Zaira, Amit Kumar, Miriam Marqués, Isabel Cortés, & Ana C. Carrera. (2006). Phosphoinositide 3‐kinase controls early and late events in mammalian cell division. The EMBO Journal. 25(4). 655–661. 108 indexed citations
19.
Marqués, Miriam, et al.. (2004). Control of Cyclin G2 mRNA Expression by Forkhead Transcription Factors: Novel Mechanism for Cell Cycle Control by Phosphoinositide 3-Kinase and Forkhead. Molecular and Cellular Biology. 24(5). 2181–2189. 161 indexed citations
20.
Nombela‐Arrieta, César, Rosa Ana Lacalle, Marı́a C. Montoya, et al.. (2004). Differential Requirements for DOCK2 and Phosphoinositide-3-Kinase γ during T and B Lymphocyte Homing. Immunity. 21(3). 429–441. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian Theisen Breakdown of academic impact, for papers by Mélanie Tichet Breakdown of academic impact, for papers by Kacper Jankowski Breakdown of academic impact, for papers by Charlotte Rorsman Breakdown of academic impact, for papers by Jacqueline Lesperance Breakdown of academic impact, for papers by Kalyani Penta Breakdown of academic impact, for papers by Takako Ooshio Breakdown of academic impact, for papers by Vinay Sagar Breakdown of academic impact, for papers by Christine Gjerdrum Breakdown of academic impact, for papers by Kumar Sukhdeo
Rankless by CCL
2026